ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NONOF Novo Nordisk (PK)

128.14
3.89 (3.13%)
Last Updated: 10:18:43
Delayed by 15 minutes

Period:

Draw Mode:

Volume 2,679
Bid Price 126.50
Ask Price 128.55
News -
Day High 128.14

Low
74.70

52 Week Range

High
140.32

Day Low 126.50
Company Name Stock Ticker Symbol Market Type
Novo Nordisk (PK) NONOF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
3.89 3.13% 128.14 10:18:43
Open Price Low Price High Price Close Price Prev Close
126.50 126.50 128.14 124.25
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12 2,679 $ 127.5466 $ 341,697 - 74.70 - 140.32
Last Trade Time Type Quantity Stock Price Currency
10:24:24 4 $ 128.14 USD

Novo Nordisk (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
570.99B 2.30B - 232.26B 83.68B 18.61 6.82
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Novo Nordisk (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NONOF Message Board. Create One! See More Posts on NONOF Message Board See More Message Board Posts

Historical NONOF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week131.25131.25119.648123.7915,325-3.11-2.37%
1 Month124.96131.40117.90126.1013,2823.182.54%
3 Months121.40140.32117.90124.7929,0776.745.55%
6 Months101.3125140.3294.36115.8132,66426.8326.48%
1 Year85.50140.3274.70104.5428,30242.6449.87%
3 Years38.695140.3236.02576.7822,33589.45231.15%
5 Years24.195140.3223.14558.3322,219103.95429.61%

Novo Nordisk (PK) Description

Novo-Nordisk is the parent company of a group engaged in the development, production and marketing of pharmaceuticals, biological solutions to industrial problems; vitamins, dietary supplements and digestive aids. Co. operates on a worldwide basis in two business segments: Diabetes care: discovery, development, manufacturing and marketing of products within the areas of insulin and delivery systems and oral antidiabetic products (OAD). Biopharmaceuticals: discovery, development, manufacturing and marketing of products within the therapy areas haemostasis management (NovoSeven(R) RT), growth hormone therapy, hormone replacement therapy and other products.

Your Recent History

Delayed Upgrade Clock